keyword
https://read.qxmd.com/read/38223603/expression-of-mir-152-in-cervical-cancer-and-its-influence-on-cisplatin-resistance
#21
JOURNAL ARTICLE
Jun Wu, Xiaoping Chi, Qian Yang, Jinxiao Li
BACKGROUND: Cervical cancer has a high mortality rate. AIM: We aimed to study the expression of micro ribonucleic acid 152 (miR-152) in cervical cancer and its influence on cisplatin (DDP) resistance. METHODOLOGY: Cervical cancer Hela cells were divided into control, DDP, DDP + mimic nc and DDP + miR-152 mimic groups. RESULTS: DDP, DDP + mimic nc and DDP + miR-152 mimic groups had lower cell survival rate, smaller number of single clones and cells penetrating the membrane, and higher apoptosis rate and miR-152 expression than those of the control group (P<0...
June 2023: African Health Sciences
https://read.qxmd.com/read/38216592/conformational-diversity-and-protein-protein-interfaces-in-drug-repurposing-in-ras-signaling-pathway
#22
JOURNAL ARTICLE
Ahenk Zeynep Sayin, Zeynep Abali, Simge Senyuz, Fatma Cankara, Attila Gursoy, Ozlem Keskin
We focus on drug repurposing in the Ras signaling pathway, considering structural similarities of protein-protein interfaces. The interfaces formed by physically interacting proteins are found from PDB if available and via PRISM (PRotein Interaction by Structural Matching) otherwise. The structural coverage of these interactions has been increased from 21 to 92% using PRISM. Multiple conformations of each protein are used to include protein dynamics and diversity. Next, we find FDA-approved drugs bound to structurally similar protein-protein interfaces...
January 12, 2024: Scientific Reports
https://read.qxmd.com/read/38214194/erbb3-governs-endothelial-dysfunction-in-hypoxia-induced-pulmonary-hypertension
#23
JOURNAL ARTICLE
Jin-Song Bian, Jingyu Chen, Junting Zhang, Jianxin Tan, Yuan Chen, Xusheng Yang, Yiying Li, Lin Deng, Rongchang Chen, Xiaowei Nie
BACKGROUND: Pulmonary hypertension, characterized by vascular remodeling, currently lacks curative therapeutic options. The dysfunction of pulmonary artery endothelial cells plays a pivotal role in the initiation and progression of pulmonary hypertension (PH). ErbB3 (human epidermal growth factor receptor 3), also recognized as HER3, is a member of the ErbB family of receptor tyrosine kinases. METHODS: Microarray, immunofluorescence, and Western blotting analyses were conducted to investigate the pathological role of ErbB3...
January 12, 2024: Circulation
https://read.qxmd.com/read/38213926/suppressed-expression-of-erbb3-binding-protein-1-ebp1-genes-compromised-the-hypersensitive-response-cell-death-in-nicotiana-benthamiana
#24
JOURNAL ARTICLE
Maho Watanabe, Kouhei Ohnishi, Yasufumi Hikichi, Akinori Kiba
Target of rapamycin (TOR) regulates essential processes associated with plant growth, development, and cell death by modulating metabolic activities and translation in response to environmental signals. The ATP-competitive TOR inhibitor AZD8055 suppressed the hypersensitive response (HR) cell death in Nicotiana benthamiana infected with the incompatible Ralstonia solanacearum . The induced expression of the HR marker gene hin1 was also inhibited by the AZD8055 treatment. To further clarify the mechanisms underlying TOR-regulated HR cell death, we focused on TOR-related ErbB3-binding protein 1 (EBP1) in N...
March 25, 2023: Plant Biotechnology (Tokyo, Japan)
https://read.qxmd.com/read/38175774/adipocyte-precursor-derived-nrg1-promotes-resistance-to-fgfr-inhibition-in-urothelial-carcinoma
#25
JOURNAL ARTICLE
Sana Hosni, Viola Kilian, Niklas Klümper, Daniela Gabbia, Katharina Sieckmann, Dillon Corvino, Anja Winkler, Miriam Saponaro, Karin Woersdoerfer, Doris Schmidt, Oliver Hahn, Ilaria Zanotto, Marina Bertlich, Marieta Toma, Tobias Bald, Markus Eckstein, Michael Hölzel, Matthias Geyer, Manuel Ritter, Dagmar Wachten, Sara De Martin, Abdullah Alajati
Aberrations of the fibroblast growth factor receptor (FGFR) family members are frequently observed in metastatic urothelial cancer (mUC), and blocking the FGF/FGFR signaling axis is used as a targeted therapeutic strategy for treating patients. Erdafitinib is a pan-FGFR inhibitor that has recently been approved by the Food and Drug Administration for mUC with FGFR2/3 alterations. Although mUC patients show initial response to erdafitinib, acquired resistance rapidly develops. Here, we found that adipocyte precursors promoted resistance to erdafitinib in FGFR-dependent bladder and lung cancer in a paracrine manner...
January 4, 2024: Cancer Research
https://read.qxmd.com/read/38150867/the-novel-antibody-fusion-protein-rhnrg1-her3i-promotes-heart-regeneration-by-enhancing-nrg1-erbb4-signaling-pathway
#26
JOURNAL ARTICLE
Xuemei Wang, Hao Wu, Luxun Tang, Wenbin Fu, Yanji He, Chunyu Zeng, Wei Eric Wang
Stimulating cardiomyocyte proliferation in the adult heart has emerged as a promising strategy for cardiac regeneration following myocardial infarction (MI). The NRG1-ERBB4 signaling pathway has been implicated in the regulation of cardiomyocyte proliferation. However, the therapeutic potential of recombinant human NRG1 (rhNRG1) has been limited due to the low expression of ERBB4 in adult cardiomyocytes. Here, we investigated whether a fusion protein of rhNRG1 and an ERBB3 inhibitor (rhNRG1-HER3i) could enhance the affinity of NRG1 for ERBB4 and promote adult cardiomyocyte proliferation...
December 26, 2023: Journal of Molecular and Cellular Cardiology
https://read.qxmd.com/read/38144565/exploration-and-validation-of-key-genes-associated-with-early-lymph-node-metastasis-in-thyroid-carcinoma-using-weighted-gene-co-expression-network-analysis-and-machine-learning
#27
JOURNAL ARTICLE
Yanyan Liu, Zhenglang Yin, Yao Wang, Haohao Chen
BACKGROUND: Thyroid carcinoma (THCA), the most common endocrine neoplasm, typically exhibits an indolent behavior. However, in some instances, lymph node metastasis (LNM) may occur in the early stages, with the underlying mechanisms not yet fully understood. MATERIALS AND METHODS: LNM potential was defined as the tumor's capability to metastasize to lymph nodes at an early stage, even when the tumor volume is small. We performed differential expression analysis using the 'Limma' R package and conducted enrichment analyses using the Metascape tool...
2023: Frontiers in Endocrinology
https://read.qxmd.com/read/38136858/genome-wide-association-analysis-identifies-the-pmel-gene-affecting-coat-color-and-birth-weight-in-simmental-%C3%A3-holstein
#28
JOURNAL ARTICLE
Jing Wang, Tingting Fan, Zhenwei Du, Lingyang Xu, Yan Chen, Lupei Zhang, Huijiang Gao, Junya Li, Yi Ma, Xue Gao
Coat color and birth weight, as easily selected traits in cattle, play important roles in cattle breeding. Therefore, we carried out a genome-wide association study on birth weight and coat color to identify loci or potential linkage regions in 233 Simmental × Holstein crossbred beef cattle. The results revealed that nine SNPs were significantly associated with coat color ( rs137169378 , rs110022687 , rs136002689 , Hypotrichosis_PMel17 , PMEL_1 , rs134930689 , rs383170073 , rs109924971 , and rs109146332 ), and these were in RNF41 , ZC3H10 , ERBB3 , PMEL , and OR10A7 on BTA5...
December 11, 2023: Animals: An Open Access Journal From MDPI
https://read.qxmd.com/read/38131395/site-specific-genetic-differences-in-colorectal-cancer-via-next-generation-sequencing-using-a-multigene-panel
#29
JOURNAL ARTICLE
Ahmet Rencuzogullari, Atil Bisgin, Kivilcim Eren Erdogan, Serdar Gumus, Orcun Yalav, Ibrahim Boga, Ozge Sonmezler, Ismail Cem Eray
AIM: Next-generation sequencing (NGS) has been proposed as a comprehensive and efficient genomic profiling tool to guide personalized therapy for colorectal cancer. This study aimed to review the site-specific difference and the potential benefits of actionable mutation panel for colorectal cancer in relation to the clinicopathological features. MATERIAL AND METHODS: One hundred and six patients who underwent colorectal surgery with curative or palliative intent for histopathologically confirmed carcinoma between June 2016 and June 2018 were identified from a prospectively maintained database...
2023: Annali Italiani di Chirurgia
https://read.qxmd.com/read/38092140/cd44s-and-cd44v8-10-isoforms-confer-acquired-resistance-to-osimertinib-by-activating-the-erbb3-stat3-signaling-pathway
#30
JOURNAL ARTICLE
Yi-Nan Liu, Meng-Feng Tsai, Shang-Gin Wu, Tzu-Hua Chang, Jin-Yuan Shih
AIMS: Although epidermal growth factor receptor (EGFR)-mutant lung cancers respond well to osimertinib, acquired resistance to osimertinib eventually develops through EGFR-dependent and EGFR-independent resistance mechanisms. CD44 splicing variants are widely expressed in lung cancer tissues. However, it remains unclear whether specific splicing variants are involved in acquired resistance to osimertinib. MAIN METHODS: The real-time PCR was performed to measure the expression levels of total CD44 and specific CD44 splicing variants (CD44s or CD44v)...
December 11, 2023: Life Sciences
https://read.qxmd.com/read/38073632/case-report-and-literature-review-exploration-of-molecular-therapeutic-targets-in-recurrent-malignant-meningioma-through-comprehensive-genetic-analysis-with-todai-oncopanel
#31
Kenta Ohara, Satoru Miyawaki, Hirofumi Nakatomi, Atsushi Okano, Yu Teranishi, Yuki Shinya, Daiichiro Ishigami, Hiroki Hongo, Shunsaku Takayanagi, Shota Tanaka, Aya Shinozaki-Ushiku, Shinji Kohsaka, Hidenori Kage, Katsutoshi Oda, Kiyoshi Miyagawa, Hiroyuki Aburatani, Hiroyuki Mano, Kenji Tatsuno, Nobuhito Saito
BACKGROUND: Despite accumulating research on the molecular characteristics of meningiomas, no definitive molecularly targeted therapy for these tumors has been established to date. Molecular mechanisms underlying meningioma progression also remain unclear. Comprehensive genetic testing approaches can reveal actionable gene aberrations in meningiomas. However, there is still limited information on whether profiling the molecular status of subsequent recurrent meningiomas could influence the choice of molecular-targeted therapies...
2023: Frontiers in Neurology
https://read.qxmd.com/read/38009810/erbb3-deficiency-causes-a-multisystemic-syndrome-in-human-patient-and-zebrafish
#32
JOURNAL ARTICLE
Keqiang Liu, Ru Chen, Minzhong Zhang, Yiming Gong, Yong Wang, Wei Cai
The Erb-B2 receptor tyrosine kinase 3 (ERBB3) gene was first identified as a cause of lethal congenital contracture syndrome (OMIM 607598), while a recent study reported six additional patients carrying ERBB3 variants which exhibited distinct clinical features with evident intestinal dysmotility (OMIM 243180). The potential connection between these phenotypes remains unknown, and the ERBB3-related phenotype spectrum needs to be better characterized. Here, we described a patient presenting with a multisystemic syndrome including skip segment Hirschsprung disease, bilateral clubfoot deformity, and cardiac defect...
November 27, 2023: Clinical Genetics
https://read.qxmd.com/read/38001709/expression-of-soluble-form-of-aurora-a-as-a-predictive-factor-for-neoadjuvant-therapy-in-breast-cancer-patients-a-single-center-pilot-study
#33
JOURNAL ARTICLE
Pawel Winter, Malgorzata Fuksiewicz, Agnieszka Jagiello-Gruszfeld, Zbigniew Nowecki, Beata Kotowicz
PURPOSE: To search for new predictive breast cancer biomarkers. We analyzed the serum concentrations of biomarkers involved in carcinogenesis, which can also be targeted by therapy. METHODS: In a single-center prospective study, the serum levels of Aurora A, thymidine kinase 1, and human epidermal growth factor receptor type 3 (HER3) were determined in 119 women with BC before neoadjuvant treatment using ELISA kits. RESULTS: The following clinical data were analyzed: age; TNM; the expression of ER, PGR, HER2, and Ki67; histological grade (G); and the response to neoadjuvant treatment (NAT) in the residual tumor burden classification (RCB)...
November 16, 2023: Cancers
https://read.qxmd.com/read/37949862/coordinate-transcriptional-regulation-of-erbb2-3-by-c-terminal-binding-protein-2-signals-sensitivity-to-erbb2-inhibition-in-pancreatic-adenocarcinoma
#34
JOURNAL ARTICLE
Kranthi Kumar Chougoni, Haemin Park, Priyadarshan K Damle, Travis Mason, Bo Cheng, Martin M Dcona, Barbara Szomju, Mikhail G Dozmorov, Michael O Idowu, Steven R Grossman
There is a critical need to identify new therapeutic vulnerabilities in pancreatic ductal adenocarcinoma (PDAC). Transcriptional co-regulators C-terminal binding proteins (CtBP) 1 and 2 are highly overexpressed in human PDAC, and CRISPR-based homozygous deletion of Ctbp2 in a mouse PDAC cell line (CKP) dramatically decreased tumor growth, reduced metastasis, and prolonged survival in orthotopic mouse allografts. Transcriptomic profiling of tumors derived from CKP vs. Ctbp2-deleted CKP cells (CKP/KO) revealed significant downregulation of the EGFR-superfamily receptor Erbb3, the heterodimeric signaling partner for both EGFR and ErbB2...
November 10, 2023: Oncogenesis
https://read.qxmd.com/read/37878223/architecture-and-topologies-of-gene-regulatory-networks-associated-with-breast-cancer-adjacent-normal-and-normal-tissues
#35
JOURNAL ARTICLE
Swapnil Kumar, Vaibhav Vindal
Most cancer studies employ adjacent normal tissues to tumors (ANTs) as controls, which are not completely normal and represent a pre-cancerous state. However, the regulatory landscape of ANTs compared to tumor and non-tumor-bearing normal tissues is largely unexplored. Among cancers, breast cancer is the most commonly diagnosed cancer and a leading cause of death in women worldwide, with a lack of sufficient treatment regimens for various reasons. Hence, we aimed to gain deeper insights into normal, pre-cancerous, and cancerous regulatory systems of breast tissues towards identifying ANT and subtype-specific candidate genes...
October 25, 2023: Functional & Integrative Genomics
https://read.qxmd.com/read/37817439/erbb3-binding-protein-1-contributes-to-adult-hippocampal-neurogenesis-by-modulating-bmp4-and-ascl1-signaling
#36
Youngkwan Kim, Hyo Rim Ko, Inwoo Hwang, Jee-Yin Ahn
Neural stem cells (NSCs) in the adult hippocampus divide infrequently; the endogenous molecules modulating adult hippocampal neurogenesis (AHN) remain largely unknown. Here, we show that ErbB3 binding protein 1 (Ebp1), which plays important roles in embryonic neurodevelopment, acts as an essential modulator of adult neurogenic factors. In vivo analysis of Ebp1 neuron depletion mice showed impaired AHN with a low number of hippocampal NSCs and neuroblasts. Ebp1 leads to transcriptional repression of Bmp4 and suppression of Ascl1 promoter methylation in the dentate gyrus of the adult hippocampus reflecting an unusually high level of Bmp4 and low Ascl1 level in neurons of Ebp1-deficient mice...
October 11, 2023: BMB Reports
https://read.qxmd.com/read/37807404/single-cell-profiling-identifies-distinct-hormonal-immunologic-and-inflammatory-signatures-of-endometriosis-constituting-cells
#37
JOURNAL ARTICLE
Sun Shin, Youn-Jee Chung, Seong Won Moon, Eun Ji Choi, Mee-Ran Kim, Yeun-Jun Chung, Sug Hyung Lee
Endometriosis consists of ectopic endometrial epithelial cells (EEECs) and ectopic endometrial stromal cells (EESCs) mixed with heterogeneous stromal cells. To address how endometriosis-constituting cells are different from normal endometrium and among endometriosis subtypes and how their molecular signatures are related to phenotypic manifestations, we analyzed ovarian endometrial cyst (OEC), superficial peritoneal endometriosis (SPE), and deep infiltrating endometriosis (DIE) from 12 patients using single-cell RNA-sequencing (scRNA-seq)...
November 2023: Journal of Pathology
https://read.qxmd.com/read/37775182/stromal-derived-nrg1-enables-oncogenic-kras-bypass-in-pancreas-cancer
#38
JOURNAL ARTICLE
Jincheng Han, Jiaqian Xu, Yonghong Liu, Shaoheng Liang, Kyle A LaBella, Deepavali Chakravarti, Denise J Spring, Yan Xia, Ronald A DePinho
Activating KRAS mutations (KRAS*) in pancreatic ductal adenocarcinoma (PDAC) drive anabolic metabolism and support tumor maintenance. KRAS* inhibitors show initial antitumor activity followed by recurrence due to cancer cell-intrinsic and immune-mediated paracrine mechanisms. Here, we explored the potential role of cancer-associated fibroblasts (CAFs) in enabling KRAS* bypass and identified CAF-derived NRG1 activation of cancer cell ERBB2 and ERBB3 receptor tyrosine kinases as a mechanism by which KRAS*-independent growth is supported...
September 29, 2023: Genes & Development
https://read.qxmd.com/read/37719042/clinicopathological-significance-of-concurrent-erbb-receptor-expression-in-human-meningioma
#39
JOURNAL ARTICLE
Sverre Helge Torp, Magnus Bossum Arnli, David Scheie
In general, human meningiomas grow slowly and have a favourable prognosis; however, some are prone to recur despite their benign histology. Therefore, knowledge of their tumour biology is essential to determine objective biomarkers that can identify cases with an increased risk for recurrence and to generate effective treatment options. Thus, studies on the epidermal growth factor receptor (EGFR) family, comprising ErbB1/EGFR, ErbB2/HER2, ErbB3/HER3 and ErbB4/HER4, are important. We have recently published papers on the expression of each of these receptor proteins in human meningiomas...
October 2023: Molecular and Clinical Oncology
https://read.qxmd.com/read/37703296/cellular-responses-after-neratinib-plus-pemetrexed-exposure-in-nsclc-cells
#40
JOURNAL ARTICLE
Laurence Booth, Andrew Poklepovic, John F Hancock, Paul Dent
We previously demonstrated that neratinib interacted with pemetrexed to kill non-small cell lung cancer (NSCLC) cells. From developing other drug combinations, we observed that several days following exposure, cells activated survival mechanisms to counteract drug toxicity. The present studies attempted to define mechanisms that evolve to reduce the efficacy of neratinib and pemetrexed. Neratinib and pemetrexed synergized to kill NSCLC cells expressing wild-type RAS proteins, mutant KRAS (G12S; Q61H; G12A and G12C) or mutant NRAS (Q61K) or mutant ERBB1 (L858R; L858R T790M and exon 19 deletion)...
October 1, 2023: Anti-cancer Drugs
keyword
keyword
1130
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.